Nautilus Biotechnology Inc (NAUT) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $2.42
• Market Cap: $365.02M
• EPS: $-0.50
• 52-Week High: $3.08
• 52-Week Low: $0.62

Market Sentiment

Nautilus Biotechnology Inc currently has a Bullish sentiment score of 0.19.

About Nautilus Biotechnology Inc

Nautilus Biotechnology Inc. is a cutting-edge life sciences company located in Seattle, Washington, dedicated to transforming proteomics with its advanced platform technology. As a development-stage firm, Nautilus aims to enhance the understanding of protein dynamics, which is critical for elucidating biological processes and underlying disease mechanisms. By addressing the intricate complexities of the proteome, Nautilus is well-positioned to facilitate breakthroughs in drug discovery and pe...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Nautilus Biotechnology Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does NAUT pay dividends?

Nautilus Biotechnology Inc (NAUT) does not currently pay a regular dividend.

What is NAUT's market cap?

Nautilus Biotechnology Inc (NAUT) has a market capitalization of $365.02M with a current stock price of $2.42.